Touchstone
Last syncNov 1, 2026, 6:55 PM ET

AVTR

Avantor, Inc. Health Care Laboratory Analytical Instruments Russell 3000
$16.05Close $10.9BMarket cap $7.41 – $17.2952-week range Late-januaryNext report · estimated

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 92 · stronger than 92% of stocks over 12 months

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 28, 2026
Off 12-month high 7%
1wk down 7.2% price change
1mo up 6.6% price change
12-month return up 45% market up 11% · its own up 28%
F-score 4 / 9 Weak
Altman Z 1.85 Moderate risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 2.0× price / book
Earnings yield down 1.7% EBIT / enterprise value
Cheaper than 51% of the market · around average
Revenue growth down 3% year on year
EPS growth — latest quarter
Sales growth up 5% latest quarter · +4 pts
ROE down 9% return on equity
Free cash margin up 8% $495.0M FCF
D/E 0.70 long-term debt / equity
Net debt / EBITDA 21.6×
Interest cover —EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • profitability slipped from last year
  • took on more long-term debt
  • issued more shares
  • gross margin narrowed
  • generating cash from operations
  • profits backed by cash
  • short-term liquidity improved
  • assets working harder

Trade setup

ATR% 3.4% $0.54 a day · 2×ATR $14.97
RS 92 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 1.1× vs 50-day average
Up/down volume 0.94 50 sessions
Implied move — no scheduled report
Trend template · 8 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

2 flagged
  • Heavily indebted Net debt is 21.6 times EBITDA — roughly 22 years of earnings before interest, tax and depreciation to repay borrowings in full.
  • Revenue shrinking Revenue fell 3.4% over the year, from $6.8B to $6.6B.
Last reported Oct 28, 2026
Results reaction Oct 28, 2026-3% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $6.6B -3% on FY2024
$0 $10B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $6.4B FY2021 · $7.4B FY2022 · $7.5B FY2023 · $7.0B FY2024 · $6.8B FY2025 · $6.6B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$530.2M down to a loss
-$1B $0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $116.6M FY2021 · $572.6M FY2022 · $686.5M FY2023 · $321.1M FY2024 · $711.5M FY2025 · -$530.2M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $495.0M -28% on FY2024
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $868.2M FY2021 · $842.5M FY2022 · $710.2M FY2023 · $723.6M FY2024 · $692.0M FY2025 · $495.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 33%
  • Net -8%
  • Free cash 8%
-10% 0% 50% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 33% · Net 2% · Free cash 14% FY2021 · Gross 34% · Net 8% · Free cash 11% FY2022 · Gross 35% · Net 9% · Free cash 9% FY2023 · Gross 34% · Net 5% · Free cash 10% FY2024 · Gross 34% · Net 10% · Free cash 10% FY2025 · Gross 33% · Net -8% · Free cash 8%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $3.6B net debt
  • Cash
  • Long-term debt
$0 $10B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $286.6M · Long-term debt $4.9B FY2021 · Cash $301.7M · Long-term debt $7.0B FY2022 · Cash $372.9M · Long-term debt $5.9B FY2023 · Cash $262.9M · Long-term debt $5.3B FY2024 · Cash $261.9M · Long-term debt $3.2B FY2025 · Cash $365.4M · Long-term debt $3.9B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 682m +17.6% since FY2020
682m 580.10m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 580.10m FY2021 · 609.70m FY2022 · 674.30m FY2023 · 676.60m FY2024 · 680.80m FY2025 · 682m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $6.4B $7.4B $7.5B $7.0B $6.8B $6.6B
Gross margin 33% 34% 35% 34% 34% 33%
Operating income $706.8M $972.2M $1.1B $696.4M $1.1B -$246.2M
Net income $116.6M $572.6M $686.5M $321.1M $711.5M -$530.2M
Net margin 2% 8% 9% 5% 10% -8%
Earnings per share $0.20 $0.95 $1.01 $0.47 $1.04 -$0.78
Free cash flow $868.2M $842.5M $710.2M $723.6M $692.0M $495.0M
Free cash margin 14% 11% 9% 10% 10% 8%
Cash $286.6M $301.7M $372.9M $262.9M $261.9M $365.4M
Long-term debt $4.9B $7.0B $5.9B $5.3B $3.2B $3.9B
Shareholders' equity $2.7B $4.2B $4.9B $5.3B $6.0B $5.6B
Shares outstanding 580.10m 609.70m 674.30m 676.60m 680.80m 682m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 28, 2026 Quarterly ↗ Sep 30, 2026 28d
Jul 29, 2026 Quarterly ↗ Jun 30, 2026 29d
Apr 29, 2026 Quarterly ↗ Mar 31, 2026 29d
Feb 11, 2026 Annual ↗ Dec 31, 2025 42d
Oct 29, 2025 Quarterly ↗ Sep 30, 2025 29d
Aug 1, 2025 Quarterly ↗ Jun 30, 2025 32d
Apr 25, 2025 Quarterly ↗ Mar 31, 2025 25d
Feb 7, 2025 Annual ↗ Dec 31, 2024 38d
Oct 25, 2024 Quarterly ↗ Sep 30, 2024 25d
Jul 26, 2024 Quarterly ↗ Jun 30, 2024 26d
Apr 26, 2024 Quarterly ↗ Mar 31, 2024 26d
Feb 14, 2024 Annual ↗ Dec 31, 2023 45d

Current reports

FiledDisclosed
Oct 28, 2026 Results ↗
Sep 21, 2026 Director or officer change · Regulation FD ↗
Sep 21, 2026 Director or officer change · Regulation FD ↗
Jul 29, 2026 Results ↗
Jul 17, 2026 Material agreement · New obligation ↗
May 12, 2026 Shareholder vote ↗
Apr 29, 2026 Results ↗
Apr 23, 2026 Director or officer change · Regulation FD ↗
Apr 1, 2026 Director or officer change · Regulation FD ↗
Feb 11, 2026 Results · Regulation FD ↗
Dec 18, 2025 Director or officer change · Regulation FD ↗
Dec 4, 2025 Director or officer change · Regulation FD ↗